PuraPharm Corporation Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was HKD 448.07 million compared to HKD 659.59 million a year ago. Net loss was HKD 120.21 million compared to HKD 121.88 million a year ago.

Basic loss per share from continuing operations was HKD 0.3047 compared to HKD 0.3095 a year ago.